Underdogs Group Secures $22.5M

TextYess

TextYess is the Autonomous CRM for eCommerce brands: a CRM, and the AI agents that run it. CRM is one of the biggest revenue drivers in ecommerce, and one of the hardest to run well. Every new channel, segment and campaign adds work, and teams rarely grow at the same pace. TextYess does that work. It brings every customer's orders, conversations and behaviour into one profile. On top of it, AI agents find the opportunities worth acting on, build the segments, write the campaigns and flows, and run them across email, WhatsApp and your website. They also answer your customers, recommend products and recover sales. Your team stays in control. The agents follow your strategy, guardrails and brand voice, and take on more autonomy as they prove their results. More CRM revenue. Less manual work. More than 350 ecommerce brands use TextYess, including Ducati, Veralab and PittaRosso. Founded in Milan in 2023 by Riccardo Russo and Edvaldo Gjonikaj. Backed by Italian Founders Fund, VC Partners and Entourage.

Ardeevo

Ardeevo is an AI-native regulatory service for MedTech manufacturers entering the European market. We support medical device and in vitro diagnostic companies with the documentation required by the MDR (EU 2017/745) and the IVDR (EU 2017/746): support in drafting technical and system documentation, reviewed by experts, at a fixed cost and on defined timelines, with milestone-based payments. The work follows three steps: AI drafting by Clark, our AI agent; validation with an expert in the loop; expert review with mandatory approval. No document is delivered without an expert's sign-off. Our services: Ardeevo Regulatory Compass — device qualification, classification and regulatory pathway Ardeevo Technical File Readiness — technical documentation, evidence, consistency of the technical file Ardeevo Lifecycle Compliance — monitoring, impact of changes, post-market surveillance Services for the quality management system (ISO 13485) We work first with manufacturers of medium-risk devices: European startups and SMEs seeking their first CE marking, and non-EU companies entering the European market. The technical documentation remains drawn up and controlled by the manufacturer; conformity assessment is the responsibility of the Notified Body. Our mission: healthcare innovation must reach patients, not stop at regulation.